CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Payments to Acquire Productive Assets
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) reported Payments to Acquire Productive Assets of $87.01 million for the 6-month period ending 2026-06-27, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireProductiveAssets · last filed 2026-08-05
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. payments to acquire productive assets for the quarter ending 2026-06-27 was $31.11M, a 11.88% decline year-over-year.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. payments to acquire productive assets for the quarter ending 2026-03-28 was $55.91M, a 5.76% decline year-over-year.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. payments to acquire productive assets for the quarter ending 2025-12-27 was $88.95M, a 17.63% increase year-over-year.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. payments to acquire productive assets for the quarter ending 2025-09-27 was $35.58M, a 8.11% decline year-over-year.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. payments to acquire productive assets for fiscal 2025 was $219.15M, a 5.93% decline from fiscal 2024.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. payments to acquire productive assets for fiscal 2024 was $232.97M, a 26.86% decline from fiscal 2023.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. payments to acquire productive assets for fiscal 2023 was $318.53M, a 1.91% decline from fiscal 2022.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. payments to acquire productive assets for fiscal 2022 was $324.73M, a 41.95% increase from fiscal 2021.
| Period end | Payments to Acquire Productive Assets 3 month | Payments to Acquire Productive Assets 6 month | Payments to Acquire Productive Assets 9 month | Payments to Acquire Productive Assets 12 month |
|---|---|---|---|---|
| 2026-06-27 | $31.11M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $87.01M 10-Q · filed 2026-08-05 | $175.96M derived: sum of 3 quarters · filed 2026-08-05 | $211.54M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-28 | $55.91M 10-Q · filed 2026-05-07 | $144.86M derived: sum of 2 quarters · filed 2026-05-07 | $180.44M derived: sum of 3 quarters · filed 2026-05-07 | $215.74M derived: sum of 4 quarters · filed 2026-05-07 |
| 2025-12-27 | $88.95M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-18 | $124.53M derived: sum of 2 quarters · filed 2026-02-18 | $159.83M derived: sum of 3 quarters · filed 2026-02-18 | $219.15M 10-K · filed 2026-02-18 |
| 2025-09-27 | $35.58M 10-Q · filed 2025-11-05 | $70.88M derived: sum of 2 quarters · filed 2025-11-05 | $130.20M 10-Q · filed 2025-11-05 | $205.82M derived: sum of 4 quarters · filed 2026-05-07 |
| 2025-06-28 | $35.30M 10-Q · filed 2025-08-06 | $94.62M 10-Q · filed 2026-08-05 | $170.24M derived: sum of 3 quarters · filed 2026-05-07 | $208.96M derived: sum of 4 quarters · filed 2026-05-07 |
| 2025-03-29 | $59.32M 10-Q · filed 2026-05-07 | $134.94M derived: sum of 2 quarters · filed 2026-05-07 | $173.66M derived: sum of 3 quarters · filed 2026-05-07 | $213.15M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-28 | $75.62M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-18 | $114.34M derived: sum of 2 quarters · filed 2026-02-18 | $153.82M derived: sum of 3 quarters · filed 2026-02-18 | $232.97M 10-K · filed 2026-02-18 |
| 2024-09-28 | $38.72M 10-Q · filed 2025-11-05 | $78.21M derived: sum of 2 quarters · filed 2025-11-05 | $157.35M 10-Q · filed 2025-11-05 | $235.67M derived: sum of 4 quarters · filed 2026-02-18 |
| 2024-06-29 | $39.49M 10-Q · filed 2025-08-06 | $118.63M 10-Q · filed 2025-08-06 | $196.95M derived: sum of 3 quarters · filed 2026-02-18 | $262.90M derived: sum of 4 quarters · filed 2026-02-18 |
| 2024-03-30 | $79.14M 10-Q · filed 2025-05-07 | $157.47M derived: sum of 2 quarters · filed 2026-02-18 | $223.41M derived: sum of 3 quarters · filed 2026-02-18 | $290.80M derived: sum of 4 quarters · filed 2026-02-18 |
| 2023-12-30 | $78.32M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-18 | $144.27M derived: sum of 2 quarters · filed 2026-02-18 | $211.65M derived: sum of 3 quarters · filed 2026-02-18 | $318.53M 10-K · filed 2026-02-18 |
| 2023-09-30 | $65.95M 10-Q · filed 2024-11-06 | $133.33M derived: sum of 2 quarters · filed 2024-11-06 | $240.21M 10-Q · filed 2024-11-06 | $329.23M derived: sum of 4 quarters · filed 2025-02-19 |
| 2023-07-01 | $67.38M 10-Q · filed 2024-08-07 | $174.26M 10-Q · filed 2024-08-07 | $263.28M derived: sum of 3 quarters · filed 2025-02-19 | $335.68M derived: sum of 4 quarters · filed 2025-02-19 |
| 2023-04-01 | $106.88M 10-Q · filed 2024-05-09 | $195.90M derived: sum of 2 quarters · filed 2025-02-19 | $268.29M derived: sum of 3 quarters · filed 2025-02-19 | $351.14M derived: sum of 4 quarters · filed 2025-02-19 |
| 2022-12-31 | $89.02M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-19 | $161.42M derived: sum of 2 quarters · filed 2025-02-19 | $244.27M derived: sum of 3 quarters · filed 2025-02-19 | $324.73M 10-K · filed 2025-02-19 |
| 2022-09-24 | $72.39M 10-Q · filed 2023-11-08 | $155.25M derived: sum of 2 quarters · filed 2023-11-08 | $235.71M 10-Q · filed 2023-11-08 | $334.48M derived: sum of 4 quarters · filed 2024-02-14 |
| 2022-06-25 | $82.85M 10-Q · filed 2023-08-09 | $163.32M 10-Q · filed 2023-08-09 | $262.09M derived: sum of 3 quarters · filed 2024-02-14 | $317.63M derived: sum of 4 quarters · filed 2024-02-14 |
| 2022-03-26 | $80.46M 10-Q · filed 2023-05-11 | $179.24M derived: sum of 2 quarters · filed 2024-02-14 | $234.78M derived: sum of 3 quarters · filed 2024-02-14 | $281.21M derived: sum of 4 quarters · filed 2024-02-14 |
| 2021-12-25 | $98.78M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-14 | $154.31M derived: sum of 2 quarters · filed 2024-02-14 | $200.74M derived: sum of 3 quarters · filed 2024-02-14 | $228.77M 10-K · filed 2024-02-14 |
| 2021-09-25 | $55.54M 10-Q · filed 2022-11-02 | $101.97M derived: sum of 2 quarters · filed 2022-11-02 | $130.00M 10-Q · filed 2022-11-02 | $217.85M derived: sum of 4 quarters · filed 2023-02-22 |
| 2021-06-26 | $46.43M 10-Q · filed 2022-08-03 | $74.46M 10-Q · filed 2022-08-03 | $162.31M derived: sum of 3 quarters · filed 2023-02-22 | $188.50M derived: sum of 4 quarters · filed 2023-02-22 |
| 2021-03-27 | $28.03M 10-Q · filed 2022-05-04 | $115.88M derived: sum of 2 quarters · filed 2023-02-22 | $142.07M derived: sum of 3 quarters · filed 2023-02-22 | $168.87M derived: sum of 4 quarters · filed 2023-02-22 |
| 2020-12-26 | $87.85M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-22 | $114.04M derived: sum of 2 quarters · filed 2023-02-22 | $140.84M derived: sum of 3 quarters · filed 2023-02-22 | $166.56M 10-K · filed 2023-02-22 |
| 2020-09-26 | $26.18M 10-Q · filed 2021-11-03 | $52.98M derived: sum of 2 quarters · filed 2021-11-03 | $78.71M 10-Q · filed 2021-11-03 | $142.54M derived: sum of 4 quarters · filed 2022-02-16 |
| 2020-06-27 | $26.80M 10-Q · filed 2021-08-04 | $52.52M 10-Q · filed 2021-08-04 | $116.36M derived: sum of 3 quarters · filed 2022-02-16 | $151.52M derived: sum of 4 quarters · filed 2022-02-16 |
| 2020-03-28 | $25.72M 10-Q · filed 2021-05-04 | $89.56M derived: sum of 2 quarters · filed 2022-02-16 | $124.72M derived: sum of 3 quarters · filed 2022-02-16 | $149.50M derived: sum of 4 quarters · filed 2022-02-16 |
| 2019-12-28 | $63.84M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-16 | $99.00M derived: sum of 2 quarters · filed 2022-02-16 | $123.78M derived: sum of 3 quarters · filed 2022-02-16 | $140.51M 10-K · filed 2022-02-16 |
| 2019-09-28 | $35.16M 10-Q · filed 2020-10-29 | $59.94M derived: sum of 2 quarters · filed 2020-10-29 | $76.67M 10-Q · filed 2020-10-29 | $145.35M derived: sum of 4 quarters · filed 2021-02-17 |
| 2019-06-29 | $24.78M 10-Q · filed 2020-08-05 | $41.51M 10-Q · filed 2020-08-05 | $110.19M derived: sum of 3 quarters · filed 2021-02-17 | $132.63M derived: sum of 4 quarters · filed 2021-02-17 |
| 2019-03-30 | $16.73M 10-Q · filed 2020-05-07 | $85.41M derived: sum of 2 quarters · filed 2021-02-17 | $107.85M derived: sum of 3 quarters · filed 2021-02-17 | $129.06M derived: sum of 4 quarters · filed 2021-02-17 |
| 2018-12-29 | $68.68M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-17 | $91.11M derived: sum of 2 quarters · filed 2021-02-17 | $112.33M derived: sum of 3 quarters · filed 2021-02-17 | $140.05M 10-K · filed 2021-02-17 |
| 2018-09-29 | $22.44M 10-Q · filed 2019-11-06 | $43.65M derived: sum of 2 quarters · filed 2019-11-06 | $71.38M 10-Q · filed 2019-11-06 | $99.88M derived: sum of 4 quarters · filed 2020-02-11 |
| 2018-06-30 | $21.21M 10-Q · filed 2019-07-31 | $48.94M 10-Q · filed 2019-07-31 | $77.44M derived: sum of 3 quarters · filed 2020-02-11 | $99.45M derived: sum of 4 quarters · filed 2020-02-11 |
| 2018-03-31 | $27.73M 10-Q · filed 2019-05-07 | $56.23M derived: sum of 2 quarters · filed 2020-02-11 | $78.24M derived: sum of 3 quarters · filed 2020-02-11 | $94.24M derived: sum of 4 quarters · filed 2020-02-11 |
| 2017-12-30 | $28.50M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-11 | $50.51M derived: sum of 2 quarters · filed 2020-02-11 | $66.51M derived: sum of 3 quarters · filed 2020-02-11 | $82.43M 10-K · filed 2020-02-11 |
| 2017-09-30 | $22.01M 10-Q · filed 2018-11-07 | $38.01M derived: sum of 2 quarters · filed 2018-11-07 | $53.93M 10-Q · filed 2018-11-07 | $79.61M derived: sum of 4 quarters · filed 2019-02-13 |
| 2017-07-01 | $16.00M 10-Q · filed 2018-08-08 | $31.92M 10-Q · filed 2018-08-08 | $57.60M derived: sum of 3 quarters · filed 2019-02-13 | $67.16M derived: sum of 4 quarters · filed 2019-02-13 |
| 2017-04-01 | $15.92M 10-Q · filed 2018-05-10 | $41.60M derived: sum of 2 quarters · filed 2019-02-13 | $51.17M derived: sum of 3 quarters · filed 2019-02-13 | $62.96M derived: sum of 4 quarters · filed 2019-02-13 |
| 2016-12-31 | $25.68M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-13 | $35.25M derived: sum of 2 quarters · filed 2019-02-13 | $47.04M derived: sum of 3 quarters · filed 2019-02-13 | $55.29M 10-K · filed 2019-02-13 |
| 2016-09-24 | $9.57M 10-Q · filed 2017-11-09 | $21.36M derived: sum of 2 quarters · filed 2017-11-09 | $29.61M 10-Q · filed 2017-11-09 | $57.85M derived: sum of 4 quarters · filed 2018-02-13 |
| 2016-06-25 | $11.79M 10-Q · filed 2017-08-09 | $20.04M 10-Q · filed 2017-08-09 | $48.28M derived: sum of 3 quarters · filed 2018-02-13 | $58.74M derived: sum of 4 quarters · filed 2018-02-13 |
| 2016-03-26 | $8.25M 10-Q · filed 2017-05-10 | $36.49M derived: sum of 2 quarters · filed 2018-02-13 | $46.95M derived: sum of 3 quarters · filed 2018-02-13 | $60.85M derived: sum of 4 quarters · filed 2018-02-13 |
| 2015-12-26 | $28.24M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-13 | $38.70M derived: sum of 2 quarters · filed 2018-02-13 | $52.60M derived: sum of 3 quarters · filed 2018-02-13 | $63.25M 10-K · filed 2018-02-13 |
| 2015-09-26 | $10.45M 10-Q · filed 2016-11-02 | $24.36M derived: sum of 2 quarters · filed 2016-11-02 | $35.01M 10-Q · filed 2016-11-02 | $62.03M derived: sum of 4 quarters · filed 2017-02-14 |
| 2015-06-27 | $13.91M 10-Q · filed 2016-08-03 | $24.56M 10-Q · filed 2016-08-03 | $51.57M derived: sum of 3 quarters · filed 2017-02-14 | $60.98M derived: sum of 4 quarters · filed 2017-02-14 |
| 2015-03-28 | $10.65M 10-Q · filed 2016-05-04 | $37.67M derived: sum of 2 quarters · filed 2017-02-14 | $47.07M derived: sum of 3 quarters · filed 2017-02-14 | $56.38M derived: sum of 4 quarters · filed 2017-02-14 |
| 2014-12-27 | $27.02M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-14 | $36.42M derived: sum of 2 quarters · filed 2017-02-14 | $45.73M derived: sum of 3 quarters · filed 2017-02-14 | $56.92M 10-K · filed 2017-02-14 |
| 2014-09-27 | $9.40M 10-Q · filed 2015-11-04 | $18.72M derived: sum of 2 quarters · filed 2015-11-04 | $29.91M 10-Q · filed 2015-11-04 | $43.74M derived: sum of 4 quarters · filed 2016-02-12 |
| 2014-06-28 | $9.31M 10-Q · filed 2015-07-30 | $20.50M 10-Q · filed 2015-07-30 | $34.34M derived: sum of 3 quarters · filed 2016-02-12 | $43.44M derived: sum of 4 quarters · filed 2016-02-12 |
| 2014-03-29 | $11.19M 10-Q · filed 2015-04-30 | $25.02M derived: sum of 2 quarters · filed 2016-02-12 | $34.12M derived: sum of 3 quarters · filed 2016-02-12 | $43.91M derived: sum of 4 quarters · filed 2016-02-12 |
| 2013-12-28 | $13.84M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-12 | $22.93M derived: sum of 2 quarters · filed 2016-02-12 | $32.73M derived: sum of 3 quarters · filed 2016-02-12 | $39.15M 10-K · filed 2016-02-12 |
| 2013-09-28 | $9.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-30 | $18.89M derived: sum of 2 quarters · filed 2014-10-30 | $25.32M 10-Q · filed 2014-10-30 | $39.06M derived: sum of 4 quarters · filed 2015-02-17 |
| 2013-06-29 | $9.79M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | $16.22M 10-Q · filed 2014-08-07 | $29.96M derived: sum of 3 quarters · filed 2015-02-17 | $40.20M derived: sum of 4 quarters · filed 2015-02-17 |
| 2013-03-30 | $6.43M 10-Q · filed 2014-04-30 | $20.17M derived: sum of 2 quarters · filed 2015-02-17 | $30.41M derived: sum of 3 quarters · filed 2015-02-17 | $39.85M derived: sum of 4 quarters · filed 2015-02-17 |
| 2012-12-29 | $13.74M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-17 | $23.98M derived: sum of 2 quarters · filed 2015-02-17 | $33.42M derived: sum of 3 quarters · filed 2015-02-17 | $47.53M 10-K · filed 2015-02-17 |
| 2012-09-29 | $10.24M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-30 | $19.68M derived: sum of 2 quarters · filed 2013-10-30 | $33.80M 10-Q · filed 2013-10-30 | $61.27M derived: sum of 4 quarters · filed 2014-02-25 |
| 2012-06-30 | $9.44M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-07-31 | $23.55M 10-Q · filed 2013-07-31 | $51.02M derived: sum of 3 quarters · filed 2014-02-25 | $59.25M derived: sum of 4 quarters · filed 2014-02-25 |
| 2012-03-31 | $14.11M 10-Q · filed 2013-05-08 | $41.58M derived: sum of 2 quarters · filed 2014-02-25 | $49.80M derived: sum of 3 quarters · filed 2014-02-25 | $56.47M derived: sum of 4 quarters · filed 2014-02-25 |
| 2011-12-31 | $27.47M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-25 | $35.69M derived: sum of 2 quarters · filed 2014-02-25 | $42.35M derived: sum of 3 quarters · filed 2014-02-25 | $49.14M 10-K · filed 2014-02-25 |
| 2011-09-24 | $8.22M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-01 | $14.88M derived: sum of 2 quarters · filed 2012-11-01 | $21.67M 10-Q · filed 2012-11-01 | $37.68M derived: sum of 4 quarters · filed 2013-02-27 |
| 2011-06-25 | $6.66M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-07 | $13.45M 10-Q · filed 2012-08-07 | $29.46M derived: sum of 3 quarters · filed 2013-02-27 | $38.59M derived: sum of 4 quarters · filed 2013-02-27 |
| 2011-03-26 | $6.79M 10-Q · filed 2012-05-04 | $22.80M derived: sum of 2 quarters · filed 2013-02-27 | $31.92M derived: sum of 3 quarters · filed 2013-02-27 | $40.36M derived: sum of 4 quarters · filed 2013-02-27 |
| 2010-12-25 | $16.01M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-27 | $25.14M derived: sum of 2 quarters · filed 2013-02-27 | $33.57M derived: sum of 3 quarters · filed 2013-02-27 | $42.86M 10-K · filed 2013-02-27 |
| 2010-09-25 | $9.13M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-02 | $17.56M derived: sum of 2 quarters · filed 2011-11-02 | $26.85M 10-Q · filed 2011-11-02 | $43.18M derived: sum of 4 quarters · filed 2012-02-27 |
| 2010-06-26 | $8.43M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-03 | $17.73M 10-Q · filed 2011-08-03 | $34.05M derived: sum of 3 quarters · filed 2012-02-27 | $52.52M derived: sum of 4 quarters · filed 2012-02-27 |
| 2010-03-27 | $9.29M 10-Q · filed 2011-05-04 | $25.62M derived: sum of 2 quarters · filed 2012-02-27 | $44.08M derived: sum of 3 quarters · filed 2012-02-27 | |
| 2009-12-26 | $16.33M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-27 | $34.79M derived: sum of 2 quarters · filed 2012-02-27 | $79.85M 10-K · filed 2012-02-27 | |
| 2009-09-26 | $18.46M derived: 10-Q 9 month − 10-Q 6 month · filed 2010-11-04 | $63.53M 10-Q · filed 2010-11-04 | ||
| 2009-06-27 | $45.06M 10-Q · filed 2010-08-03 | |||
| 2008-12-27 | $198.64M 10-K · filed 2011-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |